SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIGOLIN, Gian Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.724
EU - Europa 5.120
AS - Asia 3.379
SA - Sud America 15
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 2
Totale 22.259
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.701
CN - Cina 1.754
IT - Italia 1.553
UA - Ucraina 987
DE - Germania 882
TR - Turchia 750
SG - Singapore 587
GB - Regno Unito 452
SE - Svezia 311
FR - Francia 298
FI - Finlandia 248
PL - Polonia 142
ID - Indonesia 116
VN - Vietnam 108
RU - Federazione Russa 85
BE - Belgio 55
CZ - Repubblica Ceca 49
IN - India 24
HK - Hong Kong 12
CA - Canada 11
IE - Irlanda 11
IR - Iran 10
NL - Olanda 10
BR - Brasile 8
ES - Italia 8
EU - Europa 8
AU - Australia 7
JP - Giappone 7
SV - El Salvador 6
AT - Austria 5
KR - Corea 5
RO - Romania 5
MX - Messico 4
CH - Svizzera 3
EC - Ecuador 3
NZ - Nuova Zelanda 3
CO - Colombia 2
GR - Grecia 2
IL - Israele 2
MD - Moldavia 2
PT - Portogallo 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BD - Bangladesh 1
EE - Estonia 1
EG - Egitto 1
GT - Guatemala 1
HU - Ungheria 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 22.259
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.778
Fairfield 1.671
Houston 1.184
Jacksonville 1.118
Chandler 1.097
Ashburn 825
Ann Arbor 790
Seattle 660
Wilmington 642
Cambridge 561
Beijing 470
Izmir 436
Singapore 436
Nanjing 368
Princeton 288
Ferrara 261
New York 196
Milan 189
Boardman 160
San Diego 157
Shanghai 151
Warsaw 132
Nanchang 116
Jakarta 115
Shenyang 112
Dong Ket 108
Bremen 100
Addison 99
Rome 71
Hebei 70
Los Angeles 69
Jiaxing 67
Santa Clara 65
Tianjin 63
Dearborn 62
Changsha 60
Brussels 55
Falls Church 44
Jinan 42
Norwalk 41
Brno 38
Redwood City 36
Mountain View 34
San Mateo 34
Zhengzhou 31
London 28
Bologna 27
Munich 24
Verona 24
Naples 23
Augusta 22
Kunming 22
Ningbo 22
Bari 21
Auburn Hills 19
Washington 19
Florence 18
Guangzhou 18
Haikou 18
Des Moines 17
Lappeenranta 17
Helsinki 16
Turin 15
Hefei 14
Orange 14
San Jose 14
Hangzhou 13
Leawood 13
Taizhou 13
Tappahannock 13
Trieste 12
Lanzhou 11
Lozzo Atestino 11
Monmouth Junction 11
Monza 11
Palermo 11
Changchun 10
Hong Kong 10
Indiana 10
Olomouc 10
Parma 10
Redmond 10
Napoli 9
Philadelphia 9
Dublin 8
Genoa 8
Modena 8
Voghera 8
Mumbai 7
Padova 7
Ardabil 6
Brescia 6
Chicago 6
Chiswick 6
Fuzhou 6
Hounslow 6
Prineville 6
Reggio Nell'emilia 6
San Salvador 6
Avellino 5
Totale 15.816
Salva come PNG Salva come JPEG
Nome #
Ripristino dell’apoptosi mediata da p53: ruolo degli inibitori di MDM2. 746
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 183
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival 168
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 168
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 161
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 158
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 158
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 157
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 155
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 149
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 146
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 144
A case of disseminated Langerhans' cell histiocytosis treated with thalidomide 140
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 138
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 136
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 134
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 134
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 133
A case of advanced Hodgkin lymphoma with breast involvement treated with a combination of gemcitabine and pegylated liposomal doxorubicin. 132
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 132
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes 131
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 131
Secondary chromosome changes in mantle cell lymphoma: cytogenetic and fluorescence in situ hybridization studies. 130
Minimal morphological criteria for defining bone marrow dysplasia: A basis for clinical implementation of WHO classification of myelodysplastic syndromes 130
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 129
Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Hodgkin's Lymphoma 129
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 127
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 127
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 125
null 124
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 124
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 123
Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings. 123
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia. 122
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 122
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype 122
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 121
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 120
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 120
Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings, 119
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 118
Exercise training and endothelial progenitor cells in haemodialysis patients 118
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 118
Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: Comparison with metaphase banding analysis 116
Isolated thrombocytopenia by splenic sequestration in hemodialyzed patients 116
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 114
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 114
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 114
Hepatosplenic T-cell lymphoma (HSTCL). 113
Dendritic cells in acute promyelocytic leukaemia 113
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 113
Delirium in acute promyelocytic leukemia patients: two case reports. 113
Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients 112
Exercise capacity and circulating endothelial progenitor cells in hemodialysis patients 111
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells. 111
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 111
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia. 110
Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation 109
A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes 109
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 108
Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13) PDGFRB-NDE1 fusion 107
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 107
null 106
Cytogenetics in myelodysplastic syndromes: Old methods, new clues 106
Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells 105
The role of rHuEpo in low-risk myelodysplastic syndrome patients 105
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis. 105
Fisiologia piastrinica. 104
Angiopoietin-2 Plasma Dosage Predicts Time to First Treatment (TTFT) and Overall Survival (OS) in Chronic Lymphocytic Leukemia. 104
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 104
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 103
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 103
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 103
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 102
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 102
Simian virus 40 efficiently infects human T lymphocytes and extends their lifespan 102
Differentiation of follicular dendritic sarcoma cells into functional myeloid-dendritic cell-like elements. 101
CD34+CD33+ blast cells: Correlation with FAB subtypes 101
Intestinal T-cell lymphoma 100
null 100
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study 100
CD34 quantitative flow cytometry study of the blastic population in acute leukemias. 99
Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: A randomized, placebo- controlled, double-blind, multicenter trial 99
CLINICAL RESPONSE TO THE ASSOCIATION OF AZACITIDINE AND LENALIDOMIDE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES. A RANDOMIZED PHASE II MULTICENTER STUDY 99
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 99
B-Cell chronic lymphocytic leukemia (B-CLL) with 14q32 translocations: haematological features and clinical outcome. 98
Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) 98
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 98
INTEGRATION OF NOVEL GENE MUTATIONS INTO KARYOTYPE-BASED SUBGROUPS AS A PROGNOSTIC RISK STRATIFICATION TOOL IN CHRONIC LYMPHOCYTIC LEUKEMIA 98
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 97
Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biological significance 96
The monocytic component in myelodysplastic syndromes. 96
Reproducible Diagnosis of Chronic Lymphocytic Leukemia (CLL) By Flow Cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation Project 95
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: Correlations with aetiological and clinical-biological findings 95
null 94
Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with granulocyte colony stimulating factor and chemotherapy for autologous transplantation 93
Study of prognosis in acute myeloid leukemias (AML) by cluster analysis. 93
A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients 93
Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile 93
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 93
Totale 12.328
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 14.951
Totale 122.492
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.382 0 0 0 624 286 510 376 439 339 477 238 93
2020/20213.589 237 265 208 343 141 328 155 374 87 518 575 358
2021/20222.856 207 338 119 141 217 146 156 164 96 243 255 774
2022/20232.771 334 144 108 304 459 371 128 273 380 25 164 81
2023/20241.610 138 155 76 50 99 244 74 98 38 50 114 474
2024/2025946 182 174 543 47 0 0 0 0 0 0 0 0
Totale 22.699